Search research articles
Contact Us
Filters
Showing results (511-520 of 568) with videos related to
Page
of 57
Sort By:
Maturitas
|
January 16, 2022
Hearing impairment and frailty in later life: The Health in Men Study (HIMS)
Rong Tian, Michelle Trevenen, Andrew H Ford, et al.
Neurology
|
July 5, 2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability
Janet H Ford, David W Ayer, Qi Zhang, et al.
Headache
|
February 16, 2023
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study
Richard B Lipton, Dawn C Buse, Claire H Sandoe, et al.
The Journal of Nutrition, Health & Aging
|
May 12, 2023
Hearing Impairment and Incident Frailty in Later Life: The Health in Men Study (HIMS)
R Tian, M Trevenen, A H Ford, et al.
Cephalalgia : an International Journal of Headache
|
May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure
Dustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosine
P M Politi, F Xie, W Dahut, et al.
JMIR Research Protocols
|
September 11, 2025
Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map
Michelle A Chui, Maria E Berbakov, Aaron M Gilson, et al.
Neuroimage. Clinical
|
March 4, 2016
Prefrontal contributions to relational encoding in amnestic mild cognitive impairment
Chris M Foster, Donna Rose Addis, Jaclyn H Ford, et al.
The American Journal of the Medical Sciences
|
December 27, 2011
Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution
Danielle S Jackson, Nneka Egbuonnu, Chukwuma Umunakwe, et al.
Biochemical Pharmacology
|
January 18, 1995
Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity
H Ford, J S Driscoll, Z Hao, et al.
Page
of 57
Search research articles
Search
Showing results (511-520 of 568) with videos related to
Sort By:
Page
of 57
Maturitas
|
January 16, 2022
Hearing impairment and frailty in later life: The Health in Men Study (HIMS)
Rong Tian, Michelle Trevenen, Andrew H Ford, et al.
Neurology
|
July 5, 2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability
Janet H Ford, David W Ayer, Qi Zhang, et al.
Headache
|
February 16, 2023
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study
Richard B Lipton, Dawn C Buse, Claire H Sandoe, et al.
The Journal of Nutrition, Health & Aging
|
May 12, 2023
Hearing Impairment and Incident Frailty in Later Life: The Health in Men Study (HIMS)
R Tian, M Trevenen, A H Ford, et al.
Cephalalgia : an International Journal of Headache
|
May 21, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure
Dustin D Ruff, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosine
P M Politi, F Xie, W Dahut, et al.
JMIR Research Protocols
|
September 11, 2025
Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map
Michelle A Chui, Maria E Berbakov, Aaron M Gilson, et al.
Neuroimage. Clinical
|
March 4, 2016
Prefrontal contributions to relational encoding in amnestic mild cognitive impairment
Chris M Foster, Donna Rose Addis, Jaclyn H Ford, et al.
The American Journal of the Medical Sciences
|
December 27, 2011
Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution
Danielle S Jackson, Nneka Egbuonnu, Chukwuma Umunakwe, et al.
Biochemical Pharmacology
|
January 18, 1995
Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity
H Ford, J S Driscoll, Z Hao, et al.
Page
of 57